Emergent leads Mpox-linked stock gains as investors await approval

(Bloomberg) — Emergent BioSolutions Inc. led a rise this week in shares of companies working on vaccines and antiviral products as investors await a decision from U.S. regulators on whether the company’s smallpox vaccine can be used against the fast-spreading…